SZSE Ticker: 300199

Hybio Pharmaceutical Co., Ltd.

深圳翰宇药业股份有限公司

翰宇药业

HYBIO

Listing Date: 2011-04-07

Board: GEM

Industry Classification: Manufacturing

The concept of new crown treatment fluctuates lower – yqqlm

The concept of new crown treatment fluctuates lower – yqqlm

Pharmaceutical-related sectors fell across the board

The concept of new crown treatment fluctuates lower_Oriental Fortune Net

The concept of new crown treatment fluctuates lower

Hanyu Pharmaceutical was listed on the list of "Top 100 Shenzhen Enterprises with Innovation Strength in 2021"

Hanyu Pharmaceutical: Our company's new crown nasal spray project has only taken half a year since it was launched, and the preclinical process research has been completed.

The first five-year plan for bio-economy was issued, and concept stocks pulled up the daily limit at the end of the session. Please collect the list of the latest performance growth! Multiple consecutive daily limit, this sector started a rebound mode

2.389 billion yuan of main funds withdraw from the pharmaceutical and biological sector today_ Oriental Fortune Net

Hanyu Pharmaceutical: Tu Honghong takes office as vice president

[News] Hanyu Pharmaceutical Publishes Pledge Announcement- CFi.CN Zhongcai Network

Hanyu Pharmaceutical (300199): Appointment of senior management personnel of the company CFi.CN Zhongcai Network

Hanyu Pharmaceutical (300199): The controlling shareholder and the actual controller act in concert to handle the stock pledge repurchase business CFi.CN Zhongcai Network

Hanyu Pharmaceutical (300199): Resolution of the ninth meeting of the fifth board of directors- CFi.CN Zhongcai Network

Hanyu Pharmaceutical (300199): The company applies for bank credit CFi.CN Zhongcai Network

Hanyu Pharmaceutical (300199): Independent Opinions of Independent Directors on Matters Related to the Ninth Meeting of the Fifth Session of the Board of Directors- CFi.CN Zhongcai Network

Hanyu Pharmaceutical (300199): Adjustment of the company's 2022 restricted stock incentive plan for the first grant of related matters CFi.CN Zhongcai Network

Hanyu Pharmaceutical (300199): The Board of Supervisors' Verification Opinions on the Company's 2022 Restricted Stock Incentive Plan for the First Grant of the List of Incentive Objects (Grant Date) CFi.CN Zhongcai Network

Hanyu Pharmaceutical (300199): Resolution of the 6th Meeting of the 5th Supervisory Committee CFi.CN

Hanyu Pharmaceutical (300199): Announcement on the progress of the company's foreign investment CFi.CN

Hanyu Pharmaceutical (300199.SZ) granted 14.4 million restricted shares at a price of 9.63 yuan per share Hanyu Pharmaceutical

Want to see more data? Registered subscribers can see all the data.